Please select the option that best describes you:

Do you include bevacizumab with chemotherapy in patients with metastatic colon cancer with an intact primary tumor who have intermittent obstructive symptoms?  

How do you assess the risk of complications from including bevacizumab vs the known benefits of including it with chemotherapy?



Answer from: Medical Oncologist at Academic Institution
Sign in or Register to read more